Skip to main content
Erschienen in: Neuroradiology 8/2005

01.08.2005 | Diagnostic Neuroradiology

Posterior reversible encephalopathy syndrome: a possible late interaction between cytotoxic agents and general anaesthesia

verfasst von: P. S. Rangi, W. J. Partridge, E. S. Newlands, A. D. Waldman

Erschienen in: Neuroradiology | Ausgabe 8/2005

Einloggen, um Zugang zu erhalten

Abstract

A 49-year-old woman who had previously received treatment with cytotoxic drugs for metastatic gestational trophoblastic disease (GTD) presented with a witnessed tonic–clonic seizure, headache, confusion and blindness, 6 days after the uneventful administration of a general anaesthetic and 2 months after cessation of chemotherapy. Magnetic resonance imaging showed relatively symmetrical, subcortical, white matter abnormalities, predominantly affecting the occipital, posterior temporal and parietal lobes and the cerebellum. T2-dependent abnormalities and elevated regional apparent diffusion coefficient were present in a pattern typical for posterior reversible encephalopathy syndrome (PRES). The clinical and radiological manifestations were resolved completely with supportive therapy. This case of PRES may be a late complication of gemcitabine or cisplatin therapy precipitated by a general anaesthetic, or associated electrolyte or blood pressure disturbance.
Literatur
1.
Zurück zum Zitat Hinchey J, Chaves C, Appignani B, et al (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334:494–500CrossRefPubMed Hinchey J, Chaves C, Appignani B, et al (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334:494–500CrossRefPubMed
2.
Zurück zum Zitat Casey SO, Sampaio RC, Michel E, Truwit CL (2000) Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol 21:1199–1206PubMed Casey SO, Sampaio RC, Michel E, Truwit CL (2000) Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol 21:1199–1206PubMed
3.
Zurück zum Zitat Ay H, Buonanno FS, Schaefer PW, et al (1998) Posterior leukoencephalopathy without severe hypertension: utility of diffusion-weighted MRI. Neurology 51:1369–1376PubMed Ay H, Buonanno FS, Schaefer PW, et al (1998) Posterior leukoencephalopathy without severe hypertension: utility of diffusion-weighted MRI. Neurology 51:1369–1376PubMed
4.
Zurück zum Zitat Russell MT, Nassif AS, Cacayorin ED, et al (2001) Gemcitabine-associated posterior reversible encephalopathy syndrome: MR imaging and MR spectroscopy findings. Magn Reson Imaging 19:129–132CrossRefPubMed Russell MT, Nassif AS, Cacayorin ED, et al (2001) Gemcitabine-associated posterior reversible encephalopathy syndrome: MR imaging and MR spectroscopy findings. Magn Reson Imaging 19:129–132CrossRefPubMed
5.
Zurück zum Zitat Ito Y, Arahata Y, Goto Y, et al (1998) Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome. AJNR Am J Neuroradiol 19:415–417PubMed Ito Y, Arahata Y, Goto Y, et al (1998) Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome. AJNR Am J Neuroradiol 19:415–417PubMed
6.
Zurück zum Zitat Schwartz RB, Mulkern RV, Gudbjartsson H, Jolesz F (1998) Diffusion-weighted MR imaging in hypertensive encephalopathy: clues to pathogenesis. AJNR Am J Neuroradiol 19:859–862PubMed Schwartz RB, Mulkern RV, Gudbjartsson H, Jolesz F (1998) Diffusion-weighted MR imaging in hypertensive encephalopathy: clues to pathogenesis. AJNR Am J Neuroradiol 19:859–862PubMed
7.
Zurück zum Zitat Pamela W, Schaefer MD, Ferdinand S, et al (1997) Diffusion-weighted imaging discriminates between cytotoxic and vasogenic edema in a patient with eclampsia. Stroke 28:1082–1085PubMed Pamela W, Schaefer MD, Ferdinand S, et al (1997) Diffusion-weighted imaging discriminates between cytotoxic and vasogenic edema in a patient with eclampsia. Stroke 28:1082–1085PubMed
8.
Zurück zum Zitat Covarrubias DJ, Luetmer PH, Campeau NG (2002) Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR Am J Neuroradiol 23:1038–1048PubMed Covarrubias DJ, Luetmer PH, Campeau NG (2002) Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR Am J Neuroradiol 23:1038–1048PubMed
9.
Zurück zum Zitat Provenzale JM, Petrella JR, Cruz LC Jr, Wong JC, Engelter S, Barboriak DP (2001) Quantitative assessment of diffusion abnormalities in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 22:1455–1461 Provenzale JM, Petrella JR, Cruz LC Jr, Wong JC, Engelter S, Barboriak DP (2001) Quantitative assessment of diffusion abnormalities in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 22:1455–1461
10.
Zurück zum Zitat Port JD, Beauchamp MD Jr (1998) Reversible intracerebral pathologic entities mediated by vascular autoregulatory dysfunction. Radiographics 18:353–367PubMed Port JD, Beauchamp MD Jr (1998) Reversible intracerebral pathologic entities mediated by vascular autoregulatory dysfunction. Radiographics 18:353–367PubMed
11.
Zurück zum Zitat Hauser RA, Lacey DM, Knight MR (1998) Hypertensive encephalopathy. Magnetic resonance imaging demonstration of reversible cortical and white matter lesions. Arch Neurol 45:1078–1083 Hauser RA, Lacey DM, Knight MR (1998) Hypertensive encephalopathy. Magnetic resonance imaging demonstration of reversible cortical and white matter lesions. Arch Neurol 45:1078–1083
12.
Zurück zum Zitat Jones BV, Egelhoff JC, Patterson RJ (1997) Hypertensive encephalopathy in children. AJNR Am J Neuroradiol 18:101–106PubMed Jones BV, Egelhoff JC, Patterson RJ (1997) Hypertensive encephalopathy in children. AJNR Am J Neuroradiol 18:101–106PubMed
13.
Zurück zum Zitat Schwartz RB, Jones KM, Kalina P, et al (1992) Hypertensive encephalopathy: findings on CT, MR imaging, and SPECT imaging in 14 cases. AJR Am J Roentgenol 159:379–383PubMed Schwartz RB, Jones KM, Kalina P, et al (1992) Hypertensive encephalopathy: findings on CT, MR imaging, and SPECT imaging in 14 cases. AJR Am J Roentgenol 159:379–383PubMed
14.
Zurück zum Zitat Beausang-Linder M, Bill A (1981) Cerebral circulation in acute arterial hypertension-protective effects of sympathetic nervous activity. Acta Physiol Scand 111:193–199PubMed Beausang-Linder M, Bill A (1981) Cerebral circulation in acute arterial hypertension-protective effects of sympathetic nervous activity. Acta Physiol Scand 111:193–199PubMed
15.
Zurück zum Zitat Edvinsson L, Owman C, Sjoberg NO (1976) Autonomic nerves, mast cells and amine receptors in human brain vessels: a histochemical and pharmacological study. Brain Res 115:377–393CrossRefPubMed Edvinsson L, Owman C, Sjoberg NO (1976) Autonomic nerves, mast cells and amine receptors in human brain vessels: a histochemical and pharmacological study. Brain Res 115:377–393CrossRefPubMed
16.
Zurück zum Zitat Zoja C, Furci L, Ghilarda F, Zilio P, Benigni A, Remuzzi G (1986) Cyclosporin-induced endothelial cell injury. Lab Invest 55:455–462PubMed Zoja C, Furci L, Ghilarda F, Zilio P, Benigni A, Remuzzi G (1986) Cyclosporin-induced endothelial cell injury. Lab Invest 55:455–462PubMed
17.
Zurück zum Zitat Haug C, Duell T, Voisard R, et al (1995) Cyclosporin A stimulates endothelin release. J Cardiovasc Pharmacol 26:239–241 Haug C, Duell T, Voisard R, et al (1995) Cyclosporin A stimulates endothelin release. J Cardiovasc Pharmacol 26:239–241
18.
Zurück zum Zitat Haug C, Duell T, Lenich A, Kolb HJ, Grunert A (1995) Elevated plasma endothelin concentrations in cyclosporine treated patients after bone marrow transplantation. Bone Marrow Transplant 16:191–194PubMed Haug C, Duell T, Lenich A, Kolb HJ, Grunert A (1995) Elevated plasma endothelin concentrations in cyclosporine treated patients after bone marrow transplantation. Bone Marrow Transplant 16:191–194PubMed
19.
Zurück zum Zitat Lindeman G, Kefford R, Stuart-Harris R (1990) Cisplatin neurotoxicity. N Engl J Med 323:64–65 Lindeman G, Kefford R, Stuart-Harris R (1990) Cisplatin neurotoxicity. N Engl J Med 323:64–65
20.
Zurück zum Zitat Sugimoto S, Yamamoto YL, Nagahiro S, Diksic M (1995) Permeability change and brain tissue damage after intracarotid administration of cisplatin studied by double-tracer autoradiography in rats. J Neurooncol 24:229–240CrossRefPubMed Sugimoto S, Yamamoto YL, Nagahiro S, Diksic M (1995) Permeability change and brain tissue damage after intracarotid administration of cisplatin studied by double-tracer autoradiography in rats. J Neurooncol 24:229–240CrossRefPubMed
21.
Zurück zum Zitat Gregg RW, Molepo JM, Monpetit VJ, Mikael NZ, Redmond D, Gadi DJ (1992) Cisplatin neurotoxicity: the relationship between dosage, time, platinum concentration in neurologic tissues, and morphological evidence of toxicity. J Clin Oncol 10:795–803PubMed Gregg RW, Molepo JM, Monpetit VJ, Mikael NZ, Redmond D, Gadi DJ (1992) Cisplatin neurotoxicity: the relationship between dosage, time, platinum concentration in neurologic tissues, and morphological evidence of toxicity. J Clin Oncol 10:795–803PubMed
22.
Zurück zum Zitat Fischer S, Renz D, Schaper W, Karliczek GF (1995) In vitro effects of fentanyl, methohexital, and thiopental on brain endothelial permeability. Anesthesiology 82:451–458CrossRefPubMed Fischer S, Renz D, Schaper W, Karliczek GF (1995) In vitro effects of fentanyl, methohexital, and thiopental on brain endothelial permeability. Anesthesiology 82:451–458CrossRefPubMed
23.
Zurück zum Zitat Todd MM, Weeks J (1996) Comparative effects of propofol, pentobarbital, and isoflurane on cerebral blood flow and blood volume. J Neurosurg Anesthesiol 8:296–303PubMed Todd MM, Weeks J (1996) Comparative effects of propofol, pentobarbital, and isoflurane on cerebral blood flow and blood volume. J Neurosurg Anesthesiol 8:296–303PubMed
24.
Zurück zum Zitat Thompson CB, June CH, Sullivan KM, Thomas ED (1984) Association between cyclosporin neurotoxicity and hypomagnesaemia. Lancet 2:1116–1120CrossRefPubMed Thompson CB, June CH, Sullivan KM, Thomas ED (1984) Association between cyclosporin neurotoxicity and hypomagnesaemia. Lancet 2:1116–1120CrossRefPubMed
25.
Zurück zum Zitat Lanzinger MJ, Moretti EW, Wilderman RF, El-Moalem HE, Toffaletti JG, Moon RE (2003) The relationship between ionised and total serum magnesium concentrations during abdominal surgery. J Clin Anesth 15:245–249CrossRefPubMed Lanzinger MJ, Moretti EW, Wilderman RF, El-Moalem HE, Toffaletti JG, Moon RE (2003) The relationship between ionised and total serum magnesium concentrations during abdominal surgery. J Clin Anesth 15:245–249CrossRefPubMed
Metadaten
Titel
Posterior reversible encephalopathy syndrome: a possible late interaction between cytotoxic agents and general anaesthesia
verfasst von
P. S. Rangi
W. J. Partridge
E. S. Newlands
A. D. Waldman
Publikationsdatum
01.08.2005
Erschienen in
Neuroradiology / Ausgabe 8/2005
Print ISSN: 0028-3940
Elektronische ISSN: 1432-1920
DOI
https://doi.org/10.1007/s00234-005-1376-6

Weitere Artikel der Ausgabe 8/2005

Neuroradiology 8/2005 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Obstipation Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.